IASLC WCLC 2021: Cemiplimab Is an Effective First-Line Treatment for Locally Advanced Non–Small Cell Lung Cancer
Findings are derived from a post-hoc subgroup analysis of EMPOWER Lung-1
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.